Stockreport

Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria

Synlogic, Inc.  (SYBX) 
Last synlogic, inc. earnings: 3/12 04:19 pm Check Earnings Report
PDF Findings support positive proof of mechanism, through successful degradation of methionine, precursor to homocysteine, using dietary disease model in preclinical models [Read more]